Adagene (ADAG) Accumulated Depreciation (2019 - 2025)
Adagene's (ADAG) quarterly Accumulated Depreciation came in at $7.8 million in Q4 2025, up 7.47% year-on-year from $7.3 million in Q4 2024, and up 7.47% on a QoQ basis from $7.3 million in Q4 2024.
Adagene (ADAG) Accumulated Depreciation (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Accumulated Depreciation data on file, last reported at $7.8 million in Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 7.47% year-over-year to $7.8 million in Q4 2025; TTM through Dec 2025 was $7.8 million, a 7.47% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 7.47% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $7.8 million, up from $7.3 million in the prior quarter.
- Over the last five years, Accumulated Depreciation for ADAG reached as high as $7.8 million in Q4 2025 and fell as low as $5.3 million in Q4 2021.
- Historically, Accumulated Depreciation has averaged $6.6 million across 5 years, with a median of $6.7 million in 2023.
- Across the five-year window, Accumulated Depreciation rose 24.05% in 2021 and increased 7.47% in 2025, its largest moves.
- Year by year, Accumulated Depreciation stood at $5.3 million in 2021, then rose by 11.03% to $5.9 million in 2022, then increased by 13.52% to $6.7 million in 2023, then increased by 8.84% to $7.3 million in 2024, then gained by 7.47% to $7.8 million in 2025.
- Per Business Quant data, the three most recent Accumulated Depreciation figures were $7.8 million in Q4 2025, $7.3 million in Q4 2024, and $6.7 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.85 Mn |
| Dec 31, 2024 | 7.30 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Dec 31, 2022 | 5.91 Mn |
| Dec 31, 2021 | 5.32 Mn |
| Dec 31, 2020 | 4.29 Mn |
| Dec 31, 2019 | 3.21 Mn |